Drug Trial Radar · NCT07601425
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Jul 27, 2026
Primary completion
Dec 2027
Study completion Mar 2030
Sponsor
- Lead sponsor
- Atavistik Bio, IncIndustry
- Sponsor type
- Industry
- First posted
- May 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a 2-part study evaluating ATV-1601 in participants with moderate to severe HHT. Part 1 is a randomized, double-blind, placebo-controlled study evaluating 3 dosing regimens of ATV-1601. Patients completing Part 1 may participate in the Part 2 open-label extension to receive ATV-1601.
Conditions
- Hereditary Hemorrhagic Telangiectasia (HHT)
- Osler Weber Rendu Disease
Interventions
ATV-1601Drug
Administered orally, daily
PlaceboDrug
Administered orally, daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Safety and tolerabilityTime frame: 16 weeks
- Part 2: Safety and tolerabilityTime frame: 24 months
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
Arizona Pulmonary Specialists
Phoenix, Arizona · Recruiting
University of California, San Diego
San Diego, California · Recruiting
Augusta University Medical Center
Augusta, Georgia · Recruiting
Innovative Hematology
Indianapolis, Indiana · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Washington University in St. Louis
St Louis, Missouri · Recruiting
University of North Carolina
Chapel Hill, North Carolina · Recruiting
University of Texas Southwestern
Dallas, Texas · Recruiting
University of Utah Health Sciences Center
Salt Lake City, Utah · Recruiting
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.